Status:
RECRUITING
Metagenomics Next-generation Sequencing Approach to Detect Microbial DNA/RNA Overtime in Individuals Undergoing Hematopoietic Stem Cell Transplant
Lead Sponsor:
National Institutes of Health Clinical Center (CC)
Conditions:
Hematopoietic Stem Cell Transplantation
Eligibility:
All Genders
3-100 years
Brief Summary
Infections are a major cause of morbidity and mortality in patients undergoing hematopoietic stem cell transplant (HSCT). The purpose of this study is to evaluate if metagenomic next-generation sequen...
Detailed Description
Study Description: Infections are a major cause of morbidity and mortality in patients undergoing hematopoietic stem cell transplant (HSCT). The purpose of this study is to evaluate if metagenomic ne...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- In order to be eligible to participate in this study; an individual must meet all the following criteria:
- Male or female, aged 3 years or older.
- Co-enrolled on another study at the NIH CC, under which they will undergo HSCT.
- Stated willingness to comply with all study procedures and availability for the duration of the study.
- Ability of subject or Legally Authorized Representative (LAR) to understand and the willingness to sign a written informed consent document.
- EXCLUSION CRITERIA:
- An individual with any condition that, in the opinion of the investigator, contraindicates participation in this study, will be excluded.
Exclusion
Key Trial Info
Start Date :
April 9 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2030
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06904053
Start Date
April 9 2025
End Date
December 30 2030
Last Update
November 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892